Researchers successfully tested a simple intervention that could unlock greater anti-tumor power in therapies that use T cells -- an approach known as 'cell-based therapy,' which uses specially designed T cells to fight cancer. The team has proven an exciting concept: that the common cholesterol drug fenofibrate can boost T cells' ability to destroy human tumors.
